Jump to navigation
Today, representatives at the Sixty-fifth World Health Assembly gave their support to a new Global Vaccine Action Plan (GVAP). WHA endorsement of the GVAP marks a major milestone towards universal access to immunization.
This month, the Sabin Vaccine Institute will begin a Phase-1 clinical trial in Washington, DC to further investigate the Na-GST-1 human hookworm vaccine candidate.
Dengue outbreaks occur in countries throughout the world on an all too frequent basis. One of the latest countries to experience an outbreak of the disease is the Philippines.
For the past week, the Sabin Vaccine Institute and the Global Network for Neglected Tropical Diseases have been working with a group of organizations to raise awareness of specific issues - such a